BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Highly Access

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression

Florian R Fritzsche†, Kirsten Wassermann†, Monika Jung, Angelika Tölle, Ilka Kristiansen, Michael Lein, Manfred Johannsen, Manfred Dietel, Klaus Jung and Glen Kristiansen*

BMC Cancer 2008, 8:179 doi:10.1186/1471-2407-8-179

Accesses  

  • Last 30 days: 65 accesses
  • Last 365 days: 595 accesses
  • All time: 3303 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer

Carsten Kempkensteffen, Florian Fritzsche, Manfred Johannsen, Steffen Weikert, Stefan Hinz, Manfred Dietel, Marc-Oliver Riener, Holger Moch, Klaus Jung, Hans Krause, Kurt Miller, Glen Kristiansen BMC Cancer 2009, 9:276 (8 August 2009)

Abstract | Full text | PDF | PubMed

Research article   Open Access

GOLPH2 expression in renal cell cancer

Florian Fritzsche, Mark-Oliver Riener, Manfred Dietel, Holger Moch, Klaus Jung, Glen Kristiansen BMC Urology 2008, 8:15 (11 November 2008)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Golgi phosphoprotein 2 (GOLPH2), a potential biomarker for hepatocellular and prostatic carcinomas, is highly expressed in normal renal tubules as well as some renal cell carcinomas, rendering it unsuitable as a biomarker for renal cell cancer.

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations